Navigation Links
FDA Approves Teflaro for Bacterial Infections
Date:10/29/2010

ferson, 301-796-4988, erica.jefferson@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, ... VSCI ) shareholders have voted at the ... to approve the previously announced agreement and plan ... "We are pleased with the outcome of today,s ... both shareholder groups for approving the merger agreement," ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... , JERUSALEM , ... biopharma company, announced today that it has granted Novartis an option ... Transient Permeability Enhancer (TPE) technology for use with certain related small ... In a separate but related agreement, the MPM Bio IV NVS ...
... , MALVERN, Pa. , Jan. ... healthcare centers in the United States , St. Louis Children,s ... renowned pediatric care program with the installation of a SOMATOM® Definition ... AS is the world,s first adaptive scanner, which intelligently adapts, on ...
Cached Medicine Technology:Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 2Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 3Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 2Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 3Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 4
(Date:3/31/2015)... Dublin, OH (PRWEB) March 31, 2015 ... of the 2015 Healthiest Employers in Central Ohio, an ... local employers were named winners of the awards program, ... honored for their commitment to employee health, with outstanding ... Ohio employers are committed to creating a healthy environment ...
(Date:3/31/2015)... March 31, 2015 Stem cells may ... dangerous side effect – fistulas – according to the ... the latest issue of STEM CELLS Translational Medicine (SCTM). ... cells (ASC), which are collected from fat tissue, the ... completely healed within eight weeks of their last treatment ...
(Date:3/31/2015)... 2015 A team of Italian scientists ... anti-cancer properties, into mesothelioma cancer cells. Surviving Mesothelioma has ... its website. Click here to read it now. ... color to the spice turmeric, has limited value as ... experts at Università di Napoli Federico II are getting ...
(Date:3/31/2015)... March 31, 2015 Sleep Restfully, ... equipment and supplies, was recently selected to join the ... merchants that offer a great shipping experience, the Google ... demonstrate a track record of on-time shipping and excellent ... shoppers will see a Google Trusted Store badge and ...
(Date:3/31/2015)... 31, 2015 According to data published ... their own businesses fail within the first 18 months. ... to change those numbers for the better. , ... out of the Mahoning Valley in Ohio. YBI is ... offering clients guidance on topics such as management training, ...
Breaking Medicine News(10 mins):Health News:Safeware Recognized as a Healthiest Employer in Central Ohio 2Health News:Trial Shows Stem Cells Provide Long-Term Relief from Dangerous Crohn’s Side Effect 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Sleep Restfully, Inc. now recognized as Google Trusted Store 2Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 2Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 3
... The U.S. Military has selected iCRco, an American CR Company, as ... portable, fast and efficient diagnoses for our troops injured in battle. ... ... Military has selected iCRco, an American CR Company, as its new ...
... to Host Investor Conference Call on Monday, August 11, 2008 at 8:30am ... ... YORK, Aug. 8 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ), a biopharmaceutical ... for the treatment of life-threatening,diseases, including renal disease and cancer, today announced ...
... YORK, Aug. 8 Mergent, Inc., administrator ... underlying indexes for the,HealthShares Exchange Traded Funds, ... opening of trading on Monday August 11, ... Co. (Tokyo, Japan: 4518) in the,HealthShares(TM) Infectious ...
... MEDQ ) the largest Medical Transcription Service Organization,(MTSO) in ... ended June,30, 2008. Revenue for the second quarter of ... second quarter of 2007. The decrease in revenue,of $6.2 ... primarily due to,customer losses experienced during the second half ...
... Fairbanks campus will be home to the Eighth Conference ... conference is organized in cooperation with the Standing Committee ... international participants to address issues of importance to Arctic ... , More than150 guests are expected to attend at ...
... is available in French . , Montreal, ... patients who receive early treatment for Hepatitis C virus ... a rapid poly-functional immune response against HCV similar to ... study published in the Journal of Virology . ...
Cached Medicine News:Health News:US Military Chooses American Made iCRco Digital Radiography Systems 2Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 2Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 3Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 4Health News:Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results 5Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Infectious Disease and HealthShares(TM) Composite Indexes 2Health News:MedQuist Reports Second Quarter 2008 Results 2Health News:MedQuist Reports Second Quarter 2008 Results 3Health News:MedQuist Reports Second Quarter 2008 Results 4Health News:MedQuist Reports Second Quarter 2008 Results 5Health News:MedQuist Reports Second Quarter 2008 Results 6Health News:MedQuist Reports Second Quarter 2008 Results 7Health News:MedQuist Reports Second Quarter 2008 Results 8Health News:MedQuist Reports Second Quarter 2008 Results 9Health News:UAF to host Eighth Conference of Arctic Parliamentarians 2Health News:Early treatment is key to combating hepatitis C virus 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: